天銀機電(300342.SZ):天銀星際尚未承接SpaceX 、亞馬遜的訂單
格隆匯11月12日丨天銀機電(300342.SZ)在投資者互動平台表示,公司的控股子公司天銀星際是專業研發生產恒星敏感器的商業公司。天銀星際積極參與國內、國際展會,推動原有客户的復購與新用户的開拓,並取得了良好的成果。例如,天銀星際於2024年11月14-18日參加了在意大利米蘭舉辦的第75屆國際宇航大會(IAC),參展產品獲與會專家、技術人員、學者的廣泛關注。截至目前,天銀星際尚未承接SpaceX 、亞馬遜的訂單。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.